Micaela Bergamaschi

Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population

Fabio Efficace, Michele Baccarani, Massimo Breccia et al. · Blood · 2011 · 252 citations

Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis

Francesca Palandri, Massimo Breccia, Massimiliano Bonifacio et al. · Cancer · 2019 · 144 citations · Full text

Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinib

Fabio Efficace, Michele Baccarani, Massimo Breccia et al. · Leukemia · 2013 · 135 citations

Hematological Malignancy, Quality Of Life, Important Factor +11

Differences among young adults, adults and elderly chronic myeloid leukemia patients

Fabio Castagnetti, Gabriele Gugliotta, Michele Baccarani et al. · Annals of Oncology · 2014 · 97 citations · Full text

Hematological Malignancy, Family Medicine, Young Adults +8

Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP

Michele Baccarani, Elisabetta Abruzzese, Vincenzo Accurso et al. · Blood Advances · 2019 · 89 citations · Full text

Mixed-phenotype Acute Leukemia, Pathology, Cell Replacement Therapy +16